Cite
MLA Citation
M.G. Lebwohl et al.. “Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study.” Journal of the European Academy of Dermatology and Venereology, vol. 35, 2021, pp. 1152–1160. http://access.bl.uk/ark:/81055/vdc_100127528645.0x00003e